A. J. M. van den Eertwegh Et Al. , "Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program," UROLOGY , vol.81, no.1, pp.143-149, 2013
van den Eertwegh, A. J. M. Et Al. 2013. Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program. UROLOGY , vol.81, no.1 , 143-149.
van den Eertwegh, A. J. M., Karakiewicz, P., Bavbek, S., Rha, S. Y., Bracarda, S., Bahl, A., ... Ou, Y.(2013). Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program. UROLOGY , vol.81, no.1, 143-149.
van den Eertwegh, Alfonsus Et Al. "Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program," UROLOGY , vol.81, no.1, 143-149, 2013
van den Eertwegh, Alfonsus J. Et Al. "Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program." UROLOGY , vol.81, no.1, pp.143-149, 2013
van den Eertwegh, A. J. M. Et Al. (2013) . "Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program." UROLOGY , vol.81, no.1, pp.143-149.
@article{article, author={Alfonsus J. M. van den Eertwegh Et Al. }, title={Safety of Everolimus by Treatment Duration in Patients With Advanced Renal Cell Cancer in an Expanded Access Program}, journal={UROLOGY}, year=2013, pages={143-149} }